An efficient and simple synthesis of fused pyridazine derivatives has been developed. These fused pyridazines were used as key starting material for the preparation of new heterocyclic 
Introduction
Nitrogen heterocycles are of special interest because they constitute an important class of natural and non-natural products, many of which exhibit useful biological activities. 
Materials and Methods

Chemistry
All melting points are uncorrected and were determined on a Gallenkamp instrument.
Infrared spectra of the new compounds were measured on a Perkin-Elmer spectrophotometer model 1430 using potassium bromide pellets and frequencies are reported in cm 62, 157.12, 143.78, 142.07, 138.58, 132.20, 130.33, 129.46, 128.10, 127.28, 125.34, 120.35, 110.90, 55.34, 40.36, 40.08, 39.81, 39.53, 39.25, 38.97, 38 .69. A mixture of (3 a-i ) and POCl 3 (3ml) was refluxed for 1h at 60 0 C, after cooling the reaction mixture was added to the crushed ice. The solids which separated were filtered off and crystallized from ethanol to give (4 a-i ) respectively. All the reactions followed by T.L.C. 140.46, 134.84, 130.27, 129.17, 129.03, 128.70, 128.56, 126.96, 124.14, 120.54, 111.07, 110.90, 55.41 . 158. 09, 157.01, 155.87, 142.06, 140.30, 140.15, 132.03, 130.16, 129.68, 129.43, 128.59, 128.08, 127.24, 126.66, 126.52, 125.32, 124.19, 120.47, 110.98, 55.34, 40.36 . A mixture of (4 a-i ) (0.01mol) and different sulfonamides (sulfanilamide, sulfaguanidine, sod.-sulfaacetamide) (0.01mol) in glacial acetic acid (10ml) was refluxed for 2h. The reaction mixture was concentrated and left to cool , the solid separated was filtered off and recrystallized from ethanol to give (5 a-z' ) respectively. All the reactions followed by T.L.C.
3-(2-Methoxyphenyl
4-Chloro
4-(3-(2-Methoxyphenyl)-7-phenyl-1H-pyrazolo[4,3-d]pyridazin-4-ylamino)benzenesulfonamide (5 a )
White crystals, 87% yield, m.p. 143.78, 142.06, 138.59, 132.19, 130.32, 129.47, 128.10, 127.29, 125.34, 125.30, 120.35, 110.89, 55.34, 40.35, 40.07, 39.79, 39.52, 39.24, 38.96, 38 .68. 82, 160.53, 157.09, 143.59, 142.14, 138.04, 130.38, 130.29, 128.17, 128.03, 127.37, 127.26, 127.10, 126.89, 125.29, 120.38, 120.27, 118.38, 114.36, 114.22, 110.92, 110.77, 55.35, 55.27 . 160.66, 157.76, 157.11, 143.78, 142.16, 138.07, 134.93, 130.44, 128.99, 128.82, 128.22, 128.02, 127.45, 127.25, 120.42, 120.26, 118.27, 110.98, 110.78, 55.39 . 160. 63, 157.11, 143.78, 142.06, 138.57, 132.19, 130.32, 129.45, 128.09, 127.26, 125.33, 120.34, 110.87, 55.32, 40.35, 40.07, 39.79, 39.51, 39.24, 38.96 , 38 .68 . ppm. 157.11, 143.77, 142.06, 138.58, 132.20, 130.32, 129.46, 128.10, 127.28, 125.34, 125.30, 120.35, 110.89, 55.33, 40.07, 40.36, 39.52, 39.24, 38.96, 38.80, 38.69 . ppm. 
4-(3-(2-Methoxyphenyl
4-(3-(2-Methoxyphenyl)-7-phenylisoxazolo[4,5-d]pyridazin-4-ylamino)benzenesulfonamide (5 g )
1-(4-(3-(2-Methoxyphenyl)-7-tolyl-1H-pyrazolo
1-(4-(3-(2-Methoxyphenyl)-1,7-diphenyl-1H-pyrazolo[4,3-d]pyridazin-4-ylamino)-phenylsulfonyl)guanidine (5 m )
1-(4-(3-(2-Methoxyphenyl
1-(4-
(
1-(4-(3-(2-Methoxyphenyl)-7-tolylisoxazolo[4,5-d]pyridazin-4-ylamino
Synthesis of 3-(2-methoxyphenyl)-7-aryl-1H-pyrazolo[4,5-d]tetrazolo[4,3-d] pyridazines (6 ac ), 3-(2-methoxyphenyl)-1-phenyl-7-aryl-1H-pyrazolo[4,5-d]tetrazolo[4,3-d]pyridazines (6 d-f ), and 3-(2-methoxyphenyl)-7-arylisoxazolo[4,5-d]tetrazolo[4,3-d]pyridazines (6 g-i )
A mixture of (4 a-i ) (0.01mol) and NaN 3 (0.01mol) in DMF (10ml) was refluxed for 2h. The reaction mixture was concenterated and left to cool , the solid separated was filtered off to give (6 a-i ) respectively. All the reactions followed by T.L.C. 
3-(2-Methoxyphenyl)-7-phenyl-1H-pyrazolo[4,5-d]tetrazolo[4,3-d]pyridazine (6 a )
3-(2-Methoxyphenyl)-1-phenyl-7-tolyl-1H-pyrazolo[4,5-d]tetrazolo[4,3-d]pyridazine
(6 e ) 
3-(2-Methoxyphenyl)-7-tolylisoxazolo[4,5-d]tetrazolo[4,3-d]pyridazine (6 h )
Dark orange crystals, 39% yield, m. 
Synthesis of 3-(2-methoxyphenyl)-7-aryl-1H-pyrazolo[4,3-d]pyridazine-4-thiols (7 a-c ), 3-(2-methoxyphenyl)-1-phenyl-7-aryl-1H-pyrazolo[4,3-d]pyridazine-4-thiols (7 d-f ) and 3-(2-methoxyphenyl)-7-arylisoxazolo-1H-pyrazolo[4,5-d]pyridazine-4-thiols (7 g-i )
A mixture of (4 a-i ) (0.01mol) and thiourea (0.01mol) in ethyl alcohol (10ml) was refluxed for 2h. The reaction mixture was concenterated and left to cool , the solid separated was filtered off and recrystallized from alcohol to give (7 a-i ) respectively. All the reactions followed by T.L.C.
3-(2-Methoxyphenyl)-7-phenyl-1H-pyrazolo[4,3-d]pyridazine-4-thiol (7 a )
Orange crystals, 88% yield, m.p. 15, 149.02, 139.72, 131.25, 130.55, 129.68, 128.32, 125.64, 124.98, 122.28, 120.42, 110.93, 55.34, 40.34, 40.06, 39.79, 39.51, 39.23, 38.95 .
3-(2-Methoxyphenyl)-7-methoyphenyl-1-phenyl-1H-pyrazolo[4,3-d]pyridazine-4-thiol (7 f )
Dark 
Synthesis of 1-(3-(2-methoxyphenyl)-7-aryl-1H-pyrazolo[4,3-d]pyridazin-4-yl)hydrazines (8 ac ), 1-(3-(2-methoxyphenyl)-1-phenyl-7-aryl-1H-pyrazolo[4,3-d]pyridazin-4-yl)hydrazines (8 df ) and 1-(3-(2-methoxyphenyl)-7-arylisoxazolo-1H-pyrazolo[4,5-d]pyridazin-4-yl)hydrazines (8 g-i )
A mixture of (7 a-i ) (0.01mol) and hydrazine hydrate (0.01mol) in ethyl alcohol (10ml) was refluxed for 2h. The reaction mixture was concenterated and left to cool , the solid separated was filtered off and recrystallized from alcohol to give (8 a-i ) respectively. All the reactions followed by T.L.C. by refluxing in glacial acetic acid for 2h to give the corresponding sulfonamide derivatives (5 a-z' ) respectively as shown in (Scheme 2) and ( Table 2 ). The 13 CNMR spectrum of (5 n ) shows the following δ 160. 63, 157.11, 143.78, 142.06, 138.57, 132.19, 130.32, 129.45, 128.09, 127.26, 125.33, 120.34, 110.87, 55.32, 40.35, 40.07, 39.79, 39.51, 39.24, 38.96, 38.68 .
1-(3-(2-Methoxyphenyl
The poly nitrogen electron rich tetrazolo derivatives (6 
Biological evaluation
Cell line:
The cell lines were obtained from the American type culture collection ( ATCC, Rockville, MD). The cells were grown on RPMI-1640 medium supplemented with 10% inactivated fetal calf serum and 50µg/ml gentamycin. The cells were maintained at 37 0 C in a humidified atmosphere with 5% CO 2 and were subcultured two to three times a week.
Evaluation of the antitumor activity:
The antitumor activity was evaluated on carcinoma cell lines at the Regional center for 
Conclusion
In the present work, we report synthesis of new series of fused pyridazine compounds which is used as the key material for further transformation. The present study illustrating that pyridazine moiety reactivity towards some nucleophiles with the aim of preparing new biologically active compounds. Some of the new compounds tested against a panel human tumor cell line HCT-116 (colon cancer). Compounds (8 f ) and (8 i ) showed high reactivity towards cell line HCT-116 (colon cancer) more than the standard drug (Imatinib).
